EpiPen Profit

Mylan NV (NASDAQ: MYL) CEO Heather Bresch told a U.S. congressional committee last week that the company makes a profit of around $100 for each package of EpiPen it sells. Bresch testified in front of the committee amid a scandal in which Mylan may have unjustifiably raised the price of its...